An open trial of buspirone in the treatment of attention-deficit disorder

Human Psychopharmacology

Volumn 18, Issue 6, 2003, Pages 489-492

  Niederhofer, Helmut ^a  

^a Regional Hospital Bozen   (Italy)

Author keywords

Attention deficit disorder; Buspirone; Neurobiology; Psychopharmacology

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CLONIDINE; METHYLPHENIDATE; PLACEBO; PSYCHOSTIMULANT AGENT; SEROTONIN AGONIST;

ADOLESCENT; ADULT; AGGRESSION; ANOREXIA; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG BINDING; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG INDICATION; DRUG POTENTIATION; DRUG SELECTIVITY; DRUG USE; FATIGUE; FEMALE; FRUSTRATION; GROWTH INHIBITION; HEADACHE; HUMAN; HYPERACTIVITY; HYPOTENSION; INSOMNIA; MALE; MATURATION; MEASUREMENT; MENTAL PATIENT; OPEN STUDY; OUTPATIENT; PARESTHESIA; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SEDATION; SLEEP DISORDER; STATISTICAL SIGNIFICANCE; STOMACH PAIN; SWEATING; TIC; TREATMENT OUTCOME; URINARY DYSFUNCTION; VERTIGO;

ADOLESCENT; ADULT; ANTI-ANXIETY AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BUSPIRONE; DOPAMINE AGONISTS; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN AGONISTS; TREATMENT OUTCOME;

EID: 0041423437     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.511     Document Type: Article

References (15)

1. Arnsten AFT, Goldman-Rakic PS. 1985. Alpha-2 adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science 230: 1273-1276.
2. Biederman J, Newcorn J, Sprich S. 1991. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 148: 564-577.
3. Cohn JB, Wilcox CS, Meltzer HY. 1986. Neuroendocrine effects of buspirone in patients with generalized anxiety disorder. Am J Med 80: 36-40.
4. Crenshaw TM, Kavale KA, Forness SR, Reeve RE. 1999. Attention deficit hyperactivity disorder and the efficiacy of stimulant medication: a meta-analysis. In Advances in Learning and Behavioural Disabilities, Vol. 13, Scruggs TE, Mastropieri MA (eds). JAI Press: Greenwich Conn; 135-165.
5. Faraone SV, Biederman J, Keenan K, Tsuang MT. 1991. Separation of DSM-III attention deficit disorder and conduct disorder: evidence from a family-genetic study of American child psychiatric patients. Psychol Med 21: 109-121.
6. Firestone P. 1982. Factors associated with patients's adherence to stimulant medication. Am J Orthopsychiatry 52: 447-457.
7. Garattini S, Caccia S, Mennini T. 1982. Notes on Buspirone's mechanisms of action. J Clin Psych 43: 19-24.
8. Hunt RD. 1987. Treatment effects of oral and transdermal clonidine in relation to methylphenidate: an open pilot study in ADDH. Psychopharmacol Bull 123: 111-114.
9. Hunt RD. 1988. Attention deficit disorder: diagnosis, assessment and treatment. In Handbook of Clinical Assessment of Patients and Adolescents: A Biopsychosocial Approach, Vol. II, Kestenbaum C, Williams D (eds). New York University Press: New York; 519-561.
10. Hunt RD, Capper L, O'Connell P. 1990. Clonidine in child and adolescent psychiatry. J Child Adolesc Psychopharmacol 1: 87-101.
11. Hunt RD, Lau S, Ryu J. 1991. Alternative therapies for ADD. In Ritalin: Theory and Practice, Greenhill L (ed.). Mary Ann Liebert, Inc: New York; 75-95.
12. Hunt RD, Minderaa RB, Cohen DJ. 1985. Clonidine benefits patients with attention deficit disorder and hyperactivity: report of a double-blind placebo-controlled crossover study. J Am Acad Child Psychiatry 24: 617-629.
13. Jackson WJ, Buccafusco JJ. 1991. Clonidine enhances delayed matching-to-sample performance by young and aged monkeys. Pharmacol Biochem Behav 39: 79-84.
14. Rapport MD, Denney C, DuPaul GJ, Gardner MJ. 1994. Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 patients. J Am Acad Child Adolesc Psychiatry 33: 882-893.
15. Ward MF, Wender PH, Reimherr FW. 1993. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psych 150: 885-890.